Hester Biosciences Ltd. | Income Statement
Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
687
902
1,005
1,228
1,357
Cost of Goods Sold (COGS) incl. D&A
372
539
535
666
735
Gross Income
315
364
470
562
622
SG&A Expense
119
171
189
217
234
Unusual Expense
-
2
19
-
-
Non Operating Income/Expense
-
23
5
1
21
Interest Expense
41
48
34
35
40
Pretax Income
134
170
248
309
361
Income Tax
42
48
56
81
131
Consolidated Net Income
92
122
192
228
231
Net Income
95
125
192
235
256
Net Income After Extraordinaries
95
125
192
235
256
Net Income Available to Common
95
125
192
235
256
EPS (Basic)
11.11
14.65
22.57
27.68
30.12
Basic Shares Outstanding
9
9
9
9
9
EPS (Diluted)
11.11
14.65
22.57
27.68
30.12
Diluted Shares Outstanding
9
9
9
9
9
EBITDA
252
252
338
415
476
Other Operating Expense
2
-
-
-
8
Non-Operating Interest Income
2
1
1
1
1
Minority Interest Expense
3
3
-
8
26
About Hester Biosciences
View Profile
